Company Filing History:
2 out of 891 
1 out of 21 
1 out of 1,217 
Years Active: 1998-2004
Title: The Innovations of Jean-Pierre Hardelin
Introduction
Jean-Pierre Hardelin is a notable inventor based in Paris, France. He has made significant contributions to the field of medical science, particularly in the treatment of nerve tissue injuries. With a total of 4 patents, Hardelin's work has the potential to impact various therapeutic approaches.
Latest Patents
Hardelin's latest patents focus on the use of the KAL protein in treating retinal, renal, neuronal, and neural injuries. The KAL protein is identified as the active agent in a therapeutic composition designed for the treatment of nerve tissue injuries, including spinal cord tissue. This innovative approach also supports the treatment of renal grafts. Furthermore, the administration of KAL protein can be done locally or intravenously, making it versatile for various medical applications. Retinal disorders can similarly benefit from this therapeutic agent.
Career Highlights
Throughout his career, Jean-Pierre Hardelin has worked with prestigious institutions, including the Institut Pasteur. His research has been pivotal in advancing medical treatments and understanding the complexities of nerve tissue injuries.
Collaborations
Hardelin has collaborated with esteemed colleagues such as Christine Petit and Renaud Legouis. These partnerships have enriched his research and contributed to the development of innovative therapeutic solutions.
Conclusion
Jean-Pierre Hardelin's contributions to medical science through his patents and collaborations highlight his role as a significant inventor in the field. His work with the KAL protein offers promising avenues for treating various injuries and disorders.